Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
Doctors leading this study will give blood tests to head and neck cancer participants during
the beginning of chemotherapy treatment (also known as induction therapy) to see if these
blood tests can help predict tumor shrinkage after therapy and reduce the amount of
additional radiotherapy or chemotherapy treatment the participant may need. This study will
also examine ways to reduce overall side effects of treatment using robotic surgery,
chemotherapy and radiotherapy, or radiotherapy alone.